Safinamide New Drug Application Re-submitted to the FDA

Share

(January 5, 2015) – Newron Pharmaceuticals has re-submitted a New Drug Application for safinamide to the US Food and Drug Adminstration, following an announcement last week that the Committee for Medicinal Products for Human Use has given a positive opinion on safinamide for Europe. Read more…

Click for a printer friendly version

Back to top